Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: does it take these two to tango?

Respirology. 2015 Apr;20(3):359-60. doi: 10.1111/resp.12487. Epub 2015 Feb 11.

Authors

Maria I Velez¹, Anoop M Nambiar

Affiliation

¹ Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA; Audie L. Murphy VA Hospital, South Texas Veterans Health Care System, San Antonio, Texas, USA.

PMID: 25678074
DOI: 10.1111/resp.12487

No abstract available

Keywords: acetylcysteine; combination drug therapy; disease progression; idiopathic pulmonary fibrosis; pirfenidone.

Publication types

Editorial
Comment

MeSH terms

Acetylcysteine / administration & dosage*
Female
Humans
Idiopathic Pulmonary Fibrosis / drug therapy*
Male
Pyridones / administration & dosage*

Substances

Pyridones
Acetylcysteine